Canada Closes Antitrust Probe Into Janssen Over Biosimilars
Canada's competition watchdog is shuttering an investigation into whether drugmaker Janssen Inc. used its dominance in the market to block the entry of biosimilars that could compete with its arthritis medication...To view the full article, register now.
Already a subscriber? Click here to view full article